News Overview

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

The company's EBITDA on the operating front fell 3.2% to ₹ 318.3 crore compared to ₹ 328.9 crore in the year-ago period.

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

Revenue from operations increased by 38.8% YoY to ₹163 crore against ₹117.4 crore reported in the corresponding period last year.

Bharat Elec is the only stock to hits 52-week high in Nifty

The Board has proposed a final dividend of ₹6 per share and has also approved a new dividend policy of giving back up to 75% of free cash flow in the future.

This latest order enlarges TCS’s continued engagement with BSNL to modernise the state-run telecom operator’s mobile infrastructure.

Most of the IPO proceeds will be used for deleveraging, allowing for better margins and financial flexibility.

EBITDA increased 20.3% to ₹191.7 crore in the March 2025 quarter from ₹159.4 crore a year ago.

Headline CPI drops. There’s more to the story as core CPI remains elevated. Will RBI continue its accommodative stance as widely expected?